APVO
Aptevo Therapeutics·NASDAQ
--
--(--)
--
--(--)
APVO Filings
Filing Date
Form Description
Form Type
2026-02-03
Form 8-K - Current report
Key Events
2026-02-03 · Key Events
Form 8-K - Current report
2026-02-02
Form EFFECT - Notice of Effectiveness
2026-02-02 ·
Form EFFECT - Notice of Effectiveness
2026-01-30
Form 424B4 - Prospectus [Rule 424(b)(4)]
2026-01-30 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2026-01-28
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-28 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-26
Form DEF 14A - Other definitive proxy statements
Key Events
2026-01-26 · Key Events
Form DEF 14A - Other definitive proxy statements
2026-01-16
Form PRE 14A - Other preliminary proxy statements
Key Events
2026-01-16 · Key Events
Form PRE 14A - Other preliminary proxy statements
2026-01-09
Form 8-K - Current report
Key Events
2026-01-09 · Key Events
Form 8-K - Current report
2025-12-29
Form 8-K - Current report
Key Events
2025-12-29 · Key Events
Form 8-K - Current report
2025-12-09
Form 8-K - Current report
Key Events
2025-12-09 · Key Events
Form 8-K - Current report
2025-11-26
Form EFFECT - Notice of Effectiveness
2025-11-26 ·
Form EFFECT - Notice of Effectiveness
